Erratum to: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review [0.03%]
SGLT2抑制剂与心血管疾病：系统综述的更正
Sanjay Kalra,Rakesh Sahay,Manash P Baruah
Sanjay Kalra
Published Erratum
Cardiology and therapy. 2016 Dec;5(2):169. DOI:10.1007/s40119-016-0070-6 2016
Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review [0.03%]
钠-葡萄糖共转运蛋白2(SGLT2)抑制剂与心血管疾病：系统评价
Sanjay Kalra
Sanjay Kalra
Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel class of drugs that have been extensively investigated for the treatment of hyperglycemia in type 2 diabetes mellitus (T2DM). These drugs reduce hyperglycemia by blocking renal g...
Two-year Optical Coherence Tomography Findings after Balloon-Only Treatment of Bioresorbable Scaffold Restenosis in a Calcified Coronary Lesion: A Case Report [0.03%]
可吸收支架再狭窄的球囊治疗后光学相干断层扫描两年结果（一例报告）
Abdelhakim Allali,Mohamed Abdel-Wahab,Gert Richardt
Abdelhakim Allali
We report a case of a 65-year-old female patient treated with an everolimus-eluting bioresorbable scaffold (BRS) after rotational atherectomy of a severely calcified lesion of the left anterior descending coronary artery. The implanted BRS ...
A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation [0.03%]
阿哌沙班用于非瓣膜性房颤卒中预防的性价比系统评价研究
Carme Pinyol,Jose Mª Cepeda,Inmaculada Roldan et al.
Carme Pinyol et al.
Introduction: Economic evaluations are becoming increasingly important due to limitations in economic resources, the expense of many new treatments, the need to allocate health spending as effectively as possible, and the...
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation [0.03%]
房颤患者电复律术中达比加群与华法林的对比研究
Sufyan Benamer,Debbie Lusty,Tamara Everington
Sufyan Benamer
Introduction: Direct current cardioversion (DCCV) is considered as the most effective treatment for atrial fibrillation (AF). AF is associated with an increased risk of thromboembolism, and DCCV may increase this risk. Th...
Drug-Eluting Balloons in the Treatment of Coronary De Novo Lesions: A Comprehensive Review [0.03%]
药物洗脱球囊治疗冠状动脉节段性病变的疗效分析及再狭窄机制研究进展
Rasmus Kapalu Broge Richelsen,Thure Filskov Overvad,Svend Eggert Jensen
Rasmus Kapalu Broge Richelsen
Drug-eluting balloons (DEBs) have emerged as a new application in percutaneous coronary intervention. DEBs have proven successful in the treatment of in-stent restenosis, but their role in de novo lesions is less clear. This paper provides ...
Claire McCune,Peter McKavanagh,Ian B A Menown
Claire McCune
Introduction: Multiple significant, potentially practice changing clinical trials in cardiology have been conducted and subsequently presented throughout the past year. ...
Identification and Localization of Gold Nanoparticles in Potassium Ion Pores: Implications for Kir Blockade [0.03%]
钾离子孔道中金纳米颗粒的识别与定位：对Kir阻滞的意义
Chur Chin,Yu Shin Park
Chur Chin
Introduction: In our previous study, we found that negatively charged gold nanoparticles with spermidine have the potential of blocking inwardly rectifying potassium channels (Kir), both at the cellular and the tissue lev...
Efficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-Analysis [0.03%]
新型口服抗凝药物用于房颤消融的有效性和安全性的 meta 分析（更新版）
Ajay Vallakati,Abhishek Sharma,Mohammed Madmani et al.
Ajay Vallakati et al.
Introduction: Novel oral anticoagulants (NOACs) have been approved for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation (NVAF). A large number of patients are on NOACs when they...
Erratum to: Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases [0.03%]
地尔硫卓治疗心血管疾病临床应用的更正说明
Luis Rodríguez Padial,Gonzalo Barón-Esquivias,Antonio Hernández Madrid et al.
Luis Rodríguez Padial et al.
Published Erratum
Cardiology and therapy. 2016 Jun;5(1):83-4. DOI:10.1007/s40119-016-0062-6 2016